Insulin resistant diabetes treated with sulfated insulin
Menczel, J.; Levy, M.; Bentwich, Z.
Israel Journal of Medical Sciences 2(6): 764-768
1966
ISSN/ISBN: 0021-2180 PMID: 5956693 Accession: 024879566
PDF emailed within 1 workday: $29.90
Related References
Little, J.A.; Arnott, J.H. 1966: Sulfated insulin in mild, moderate, severe and insulin-resistant diabetes mellitus Diabetes 15(7): 457-465Arnott, J.H.; Little, J.A. 1965: Sulfated insulin in mild, moderate, brittle and insulin-resistant diabetes mellitus Can Med J 92(7): 346-347
Boulet, P.; Mirouze, J.; Fruteau De Laclos, C. 1953: Single daily injection of a mixture of three insulins (regular insulin, protamine-zinc insulin and NPH insulin) in the therapy of insulin-unstable and insulin-resistant diabetes mellitus La Presse Medicale 61(70): 1428-1430
Nishimura, H.; Iizuka, K.; Takeda, J. 2014: Protamine-containing insulin but not analog insulin and duration of insulin use are risk factors for the production of insulin autoantibodies in insulin-treated patients with diabetes mellitus Endocrine Journal 61(6): 635-640
Csima, A. 1972: 4 year assessment of plasma insulin antibody content and avidity in diabetics treated with lente insulin or sulfated insulin Clinical Research: 945
Lee, K.S.; Kim, H.Y.; Jin, H.Y. 2022: Factors affecting the health status of patients with type 2 diabetes mellitus receiving insulin treatments: a multi-mediation path analysis: Influences on insulin-treated diabetes: Influences on insulin-treated diabetes Journal of Clinical Nursing 31(9-10): 1285-1297
Jehle, P.M.; Fussgaenger, R.D.; Kunze, U.; Dolderer, M.; Warchol, W.; Koop, I. 1996: The human insulin analog insulin lispro improves insulin binding on circulating monocytes of intensively treated insulin-dependent diabetes mellitus patients Journal of Clinical Endocrinology and Metabolism 81(6): 2319-2327
MacCuish, A.C.; Jordan, J.; Campbell, C.J.; Duncan, L.J.; Irvine, W.J. 1975: Cell-mediated immunity in diabetes mellitus; lymphocyte transformation by insulin and insulin fragments in insulin-treated and newly-diagnosed diabetes Diabetes 24(1): 36-43
Nyholm, B.; Fisker, S.; Lund, S.; Møller, N.; Schmitz, O. 1997: Increased circulating leptin concentrations in insulin-resistant first-degree relatives of patients with non-insulin-dependent diabetes mellitus: relationship to body composition and insulin sensitivity but not to family history of non-insulin-dependent diabetes mellitus European Journal of Endocrinology 136(2): 173-179
Rosenfalck, A.M.; Thorsby, P.; Kjems, L.; Birkeland, K.; Hanssen, K.; Madsbad, S. 1999: Effects of the rapid-acting insulin analoque Insulin Aspart on postprandial glycaemic excursions compared to human soluble insulin Actrapid given immediately or 30 minutes before a meal in insulin treated Type 2 diabetes patients Diabetes 48(Suppl 1): A116
Pedersen, O.; Hjøllund, K.E.; Beck-Nielsen, H.; Schwartz-Sørensen, N. 1986: Insulin receptors and the effect of insulin. Possible pathogenetic significance of abnormalities of insulin receptors and post-receptor function in diabetes mellitus and other insulin-resistant conditions Ugeskrift for Laeger 148(15): 883-889
Little, J.A.; Lee, R.; Sebriakova, M.; Csima, A. 1977: Insulin antibodies and clinical complications in diabetics treated for five years with lente or sulfated insulin Diabetes 26(10): 980-988
Moloney, P.J.; Aprile, M.A.; Wilson, S. 1964: Sulfated Insulin for Treatment of Insulin-Resistant Diabetics Journal of New Drugs 4(5): 258-263
Fulcher, G.R.; Christiansen, J.S.; Bantwal, G.; Polaszewska-Muszynska, M.; Mersebach, H.; Andersen, T.H.; Niskanen, L.K. 2014: Comparison of insulin degludec/insulin aspart and biphasic insulin aspart 30 in uncontrolled, insulin-treated type 2 diabetes: a phase 3a, randomized, treat-to-target trial Diabetes Care 37(8): 2084-2090
Usala, A.L.; Madigan, T.; Burguera, B.; Sinha, M.K.; Caro, J.F.; Cunningham, P.; Powell, J.G.; Butler, P.C. 1992: Treatment of insulin-resistant diabetic ketoacidosis with insulin-like growth factor I in an adolescent with insulin-dependent diabetes The new England Journal of Medicine 327(12): 853-857
Karam, J.H.; Grodsky, G.M.; Forsham, P.H. 1969: Insulin-resistant diabetes with autoantibodies induced by exogenous insulin. Successful treatment by insulin withdrawal Diabetes 18(7): 445-454
Nyholm, B.; Fineman, M.S.; Koda, J.E.; Schmitz, O. 1998: Plasma amylin immunoreactivity and insulin resistance in insulin resistant relatives of patients with non-insulin-dependent diabetes mellitus Hormone and Metabolic Research 30(4): 206-212
Usala, A.L.; Madigan, T.; Burguera, B.; Sinha, M.K.; Caro, J.F.; Cunningham, P.; Powell, J.G.; Butler, P.C. 1992: Brief report: treatment of insulin-resistant diabetic ketoacidosis with insulin-like growth factor I in an adolescent with insulin-dependent diabetes New England Journal of Medicine 327(12): 853-857
Naquet, P.; Ellis, J.; Kenshole, A.; Semple, J.W.; Delovitch, T.L. 1989: Sulfated beef insulin treatment elicits CD8+ T cells that may abrogate immunologic insulin resistance in type I diabetes Journal of Clinical Investigation 84(5): 1479-1487
Alekseeva, G.G.; Volkova, E.A.; Iukhlova, N.A. 1983: Role of insulin antagonists in the pathogenesis of insulin--sensitive and insulin-resistant diabetes mellitus Vestnik Akademii Meditsinskikh Nauk SSSR 1983(2): 39-43